HAVCR2 and acute myeloid leukemia: Recently, upregulated ICP expressions including PD-1, TIM-3, LAG-3 in addition to expansion of myeloid-derived suppressor cells and increased Treg frequency in the BMM of AML patients were reported, which highlights the importance of IC blockade as a novel therapeutic strategy in the treatment of the disease (133).